COMPARITIVE STUDY BETWEEN OF INTRARHECAL BUTORPHANOL AND INTRATHECAL NALBUPHINE AS ADJUVANTS TO 0.5% HYPERBARIC BUPIVACAINE

Dr. B. Durga Venkatram; Dr. P. V. Phaneendra Babu; Dr. Ch. Aditya Trilochan; Dr. D. Sri Vidya

Volume : IX, Issue : VI, June - 2019

COMPARITIVE STUDY BETWEEN OF INTRARHECAL BUTORPHANOL AND INTRATHECAL NALBUPHINE AS ADJUVANTS TO 0.5% HYPERBARIC BUPIVACAINE

Dr. B. Durga Venkatram, Dr. P. V. Phaneendra Babu, Dr. Ch. Aditya Trilochan, Dr. D. Sri Vidya

Abstract :

Background : spinal opiates have been of much interest in recent times as they potentiate the effect of local anaesthetic agent and provide prolonged post operative analgesia. Methods : A randomized clinical trial was conducted in Alluri Sitarama Raju academy of medical sciences, Eluru between 2017 to 2019. 60 patients scheduled for elective lower abdominal and orthopedic surgeries were randomly divided into two groups. Group B received 0.2 mg butorphanol and Group N received 0.8 mg Nalbuphine. Onset of sensory and motor blockade, duration of two segment regression and duration of analgesia were assessed. Results : It was found from our study that in nalbuphine group there was early onset of motor blockade, duration of analgesia, duration of motor blockade and time for two segment regression were significantly prolonged when compared to butorphanol group. CONCLUSION: We conclude that nalbuphine is a better neuraxial adjuvant compared to butorphanol for providing early onset of sensory and motor blockade and prolonged duration of analgesia and motor blockade.